Teva Pharma Australia

Teva Pharma Australia is the local subsidiary of Teva Pharmaceutical Industries, a global leader in generic and specialty medicines. The company provides a broad portfolio of high-quality generic drugs alongside innovative specialty treatments focusing on the central nervous system, respiratory conditions, and oncology. Key products in the Australian market include Ajovy for migraine prevention, Austedo for movement disorders, and Copaxone for multiple sclerosis. Teva plays a critical role in the Australian healthcare system by improving access to affordable medicines and supporting patient care through diverse therapeutic solutions. The company also maintains a significant presence in the biosimilars market, leveraging its global R&D and manufacturing scale.